ArticleBiomedicines2022

Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies.

Gianfranco Alicandro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.